Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have been ...
Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise ...
Debate over the risks and benefits of the population weight loss drugs like Ozempic, Wegovy, and Zepbound finally came to an ...
A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including ...
Losing weight on a GLP-1 medication can have emotional and physical effects. Some changes are easier to handle than others, ...
Of late, there have been many questions about maintaining weight loss after using Ozempic (semaglutide) and whether the ...
Topiramate, primarily used for epilepsy and migraine prevention, is emerging as a cost-effective treatment for weight loss ...
After battling with her own GI issues, Krystyna Houser took to innovating the Elemental Diet, a medical food which also ...
A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...
Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...
Nearly 70% of adults in Indiana are classified as overweight or obese, contributing to a broader health crisis in the United ...
Learn more about a new study claiming that GLP-1s could be used to treat cognitive conditions like dementia, but may pose a ...